Table 3 Change from baseline in MIDAS absenteeism (days), presenteeism (days), and total lost productive days
|  | Lasmiditan 100 mg (n = 972) | Lasmiditan 200 mg (n = 1063) | |||
|---|---|---|---|---|---|
Change from BL* | Change from BL* | ||||
LS mean* | % change in mean | LS mean | % change in mean | ||
Absenteeism (days) | BL, mean a | 3.1 | 3.2 | ||
Month 3 | −0.6 | −20.2 | −0.8 | −25.1 | |
Month 6 | −0.9 | −29.2 | − 0.9 | −29.5 | |
Month 9 | −1.0 | −32.4 | −1.0 | −30.7 | |
Month 12 | −1.0 | −32.4 | −1.2 | −38.6 | |
Presenteeism (days) | BL, mean a | 6.3 | 6.2 | ||
Month 3 | −1.5 | −24.1 | −1.4 | −21.7 | |
Month 6 | −2.1 | −32.4 | −1.8 | −29.3 | |
Month 9 | −2.3 | −36.1 | −1.8 | −29.6 | |
Month 12 | −2.6 | −40.3 | −2.3 | −37.2 | |
Total lost productive daysb | BL, mean | 9.4 | 9.4 | ||
Month 3 | −2.2 | −23.4 | −2.2 | − 23.4 | |
Month 6 | −3.0 | −31.9 | −2.8 | −29.8 | |
Month 9 | −3.3 | −35.1 | −2.8 | −29.8 | |
Month 12 | −3.6 | −38.3 | − 3.5 | −37.2 | |